Antihypertensive treatments, cognitive decline, and dementia.
about
Defining the Relationship Between Hypertension, Cognitive Decline, and Dementia: a Review.Impact of aerobic exercise on neurobehavioral outcomesPotential for specific dihydropyridine calcium channel blockers to have a positive impact on cognitive function in humans: a systematic review.Antemortem pulse pressure elevation predicts cerebrovascular disease in autopsy-confirmed Alzheimer's disease.Age-associated reductions in cerebral blood flow are independent from regional atrophy.International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli [corrected].Angiotensin II AT(1) receptor blockers as treatments for inflammatory brain disorders.Cardiovascular risk factors promote brain hypoperfusion leading to cognitive decline and dementia.Angiotensin-converting enzyme inhibitors and incidence of mild cognitive impairment. The Italian Longitudinal Study on Aging.Hypertension and Its Role in Cognitive Function: Current Evidence and Challenges for the FutureHypertension, brain damage and cognitive decline.The brain renin-angiotensin system: a diversity of functions and implications for CNS diseases.Selective antihypertensive dihydropyridines lower Aβ accumulation by targeting both the production and the clearance of Aβ across the blood-brain barrier.Involvement of Type 1 Angiontensin II Receptor (AT1) in Cardiovascular Changes Induced by Chronic Emotional Stress: Comparison between Homotypic and Heterotypic Stressors.Perindopril may improve the hippocampal reduced glutathione content in rats.Screening for mild cognitive impairment in patients with cardiovascular risk factors.Developing Cognitive Markers of Alzheimer's Disease for Primary Care: Implications for Behavioral and Global Prevention.Impact of hypertension severity on arterial stiffness, cerebral vasoreactivity, and cognitive performance.Blood pressure responses to hypertension treatment and trends in cognitive function in patients with initially difficult-to-treat hypertension: a retrospective subgroup analysis of the Observational Study on Cognitive Function and SBP Reduction (OSC
P2860
Q30235254-78176073-FF90-4B01-B718-3DE80810E0CBQ35064010-D7DB6E00-384B-4A87-B900-D60E3D75C409Q35780850-B22BA05D-1293-4164-B623-4D78E27A14EBQ36019344-C4951865-CA9D-413F-A4E3-B6C4E89830D1Q36214757-2532923B-11FC-4F87-A74B-C4E100C9F413Q36241932-78336FA2-7708-4608-93DF-A4BEBEB2191AQ36410269-4DC61542-5523-4B9A-A7D3-7BCFB5ED6190Q36455581-14F2148B-E4A9-4865-81A4-9FD698A62948Q36670162-684B488A-75AC-4BB9-88D0-CDA9FC75F4ECQ37184753-C9E541DD-903A-4B5A-93C3-544D929B9C64Q37337605-4ED2FB20-F2E4-4263-A7C9-20985549CF47Q38005611-0CE26CAA-2B09-4D67-9FFB-F1513C0D3529Q39618144-AC0459FC-DAAC-4550-82FB-320FC28204FEQ41697456-6EECE82A-049A-4BEA-95EB-4DE158098887Q41870373-C3611FD9-9DDB-4123-B61A-77F6F29BC5E2Q47107758-80F339F1-44EB-4224-B55F-EA37FED605A5Q47391689-693DAD7B-F02B-4379-B86B-937BD6579489Q47553507-93E75067-557F-4A02-842E-691DCE5DCF8CQ50771406-5AC6E8F1-5BA0-4497-A557-A9FFBC0D3F97
P2860
Antihypertensive treatments, cognitive decline, and dementia.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Antihypertensive treatments, cognitive decline, and dementia.
@en
Antihypertensive treatments, cognitive decline, and dementia.
@nl
type
label
Antihypertensive treatments, cognitive decline, and dementia.
@en
Antihypertensive treatments, cognitive decline, and dementia.
@nl
prefLabel
Antihypertensive treatments, cognitive decline, and dementia.
@en
Antihypertensive treatments, cognitive decline, and dementia.
@nl
P356
P1476
Antihypertensive treatments, cognitive decline, and dementia.
@en
P2093
Emmanuelle Duron
Olivier Hanon
P304
P356
10.3233/JAD-2010-091552
P577
2010-01-01T00:00:00Z